Metastatic Breast Cancer: Overview of Treatment

Suhail M. Ali; H. A. Harvey; Allan Lipton

doi:10.1097/01.blo.0000092981.12414.7b

Metastatic Breast Cancer: Overview of Treatment

Suhail M. Ali, H. A. Harvey, Allan Lipton

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Abstract

Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.

Original language	English (US)
Pages (from-to)	S132-S137
Journal	Clinical orthopaedics and related research
Volume	415
Issue number	SUPPL.
DOIs	https://doi.org/10.1097/01.blo.0000092981.12414.7b
State	Published - Oct 2003

All Science Journal Classification (ASJC) codes

Surgery
Orthopedics and Sports Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/01.blo.0000092981.12414.7b

Cite this

@article{b775b546f67240c4a5dc5467f9526d2a,

title = "Metastatic Breast Cancer: Overview of Treatment",

abstract = "Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.",

author = "Ali, {Suhail M.} and Harvey, {H. A.} and Allan Lipton",

year = "2003",

month = oct,

doi = "10.1097/01.blo.0000092981.12414.7b",

language = "English (US)",

volume = "415",

pages = "S132--S137",

journal = "Clinical orthopaedics and related research",

issn = "0009-921X",

publisher = "Wolters Kluwer Health Inc",

number = "SUPPL.",

}

TY - JOUR

T1 - Metastatic Breast Cancer

T2 - Overview of Treatment

AU - Ali, Suhail M.

AU - Harvey, H. A.

AU - Lipton, Allan

PY - 2003/10

Y1 - 2003/10

N2 - Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.

AB - Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=0142157076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142157076&partnerID=8YFLogxK

U2 - 10.1097/01.blo.0000092981.12414.7b

DO - 10.1097/01.blo.0000092981.12414.7b

M3 - Article

C2 - 14600603

AN - SCOPUS:0142157076

SN - 0009-921X

VL - 415

SP - S132-S137

JO - Clinical orthopaedics and related research

JF - Clinical orthopaedics and related research

IS - SUPPL.

ER -

Metastatic Breast Cancer: Overview of Treatment

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this